Kevin Kalinsky
- Oncology top 1%
- Pulmonary and Respiratory Medicine top 2%
- Molecular Biology top 10%
- Cancer Research top 2%
- Radiology, Nuclear Medicine and Imaging top 2%
- Co-authors
- Aditya BardiaSara M. TolaneyHope S. RugoDavid M. GoldenbergJoyce O’ShaughnessyWilliam A. WegenerJennifer R. DiamondLinda T. Vahdat
- Topics
- Advanced Breast Cancer Therapies (63 papers)HER2/EGFR in Cancer Research (53 papers)Cancer Treatment and Pharmacology (44 papers)
- Journals
- New England Journal of MedicineJournal of Clinical OncologySHILAP Revista de lepidopterología
- Partner nations
- United StatesSpainFrance
In The Last Decade
Kevin Kalinsky
135 papers receiving 3.0k citations
Hit Papers
Peers
Comparison fields: 5 of 108
- Oncology 2.1k
- Pulmonary and Respiratory Medicine 994
- Molecular Biology 853
- Cancer Research 728
- Radiology, Nuclear Medicine and Imaging 559
Countries citing papers authored by Kevin Kalinsky
This map shows the geographic impact of Kevin Kalinsky's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kevin Kalinsky with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kevin Kalinsky more than expected).
Fields of papers citing papers by Kevin Kalinsky
This network shows the impact of papers produced by Kevin Kalinsky. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kevin Kalinsky. The network helps show where Kevin Kalinsky may publish in the future.
Co-authorship network of co-authors of Kevin Kalinsky
This figure shows the co-authorship network connecting the top 25 collaborators of Kevin Kalinsky. A scholar is included among the top collaborators of Kevin Kalinsky based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kevin Kalinsky. Kevin Kalinsky is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 1 | |
| 3 | 1 | |
| 4 | 16 | |
| 5 | 1 | |
| 6 | 1 | |
| 7 | 5 | |
| 8 | 2 | |
| 9 | 6 | |
| 10 | 22 | |
| 11 | 18 | |
| 12 | 13 | |
| 13 | 90 | |
| 14 | 41 | |
| 15 | 39 | |
| 16 | 12 | |
| 17 | 13 | |
| 18 | 11 | |
| 19 | 13 | |
| 20 | 299 |
About Kevin Kalinsky
Kevin Kalinsky is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine, having authored 150 papers that have together received 3.1k indexed citations. Recurring topics across this work include Advanced Breast Cancer Therapies (63 papers), HER2/EGFR in Cancer Research (53 papers) and Cancer Treatment and Pharmacology (44 papers). The work is most often cited by research in Oncology (2.1k citations), Cancer Research (728 citations) and Pulmonary and Respiratory Medicine (994 citations). Kevin Kalinsky has collaborated with scholars based in United States, Spain and France. Frequent co-authors include Aditya Bardia, Sara M. Tolaney, Hope S. Rugo, David M. Goldenberg, Joyce O’Shaughnessy, William A. Wegener, Jennifer R. Diamond, Linda T. Vahdat, Robert M. Sharkey and Vandana G. Abramson. Their work appears in journals such as New England Journal of Medicine, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.